Herpes - Preliminary 48-Week Results From Clinical Study Of HIV Protease
Preliminary 48-Week Results From Clinical Study Of HIV Protease Medical News Today (press release), UK - May 17, 2006 is indicated in combination with other antiretroviral agents for the treatment of HIV that have been hidden in your body, such as pneumonia, herpes virus, or Global Men's Medicine Market Surges Past $19 Billion Yahoo! News (press release) - May 18, 2006 in the sexual function, sexually transmitted disease, cancer, and urinary treatment segments have and conditions of major concern to men, such as herpes and HIV HIV care should include routine STI screens, finds study Aidsmap, UK - May 18, 2006 that 25% of HIV transmissions could be averted by treatment for sexually and the investigators speculate that these ulcers were caused by herpes simplex virus-2 Battling Herpes without Chemicals Fashion Monitor Toronto, Canada - May 16, 2006 There are various reasons for herpes outbreak: stress, low immune system, sun exposure There are a number of options for treatment, such as cr mes and tablets BioAlliance Pharma starts pivotal Phase III clinical trial in the PharmaLive.com (press release), PA - May 16, 2006 product. A second product, acyclovir Lauriad(R), for the treatment of oral herpes, has completed a Phase I clinical trial in Europe. A Doctors develop tool for diagnosing immune reconstitution syndrome Aidsmap, UK - May 18, 2006 zoster as a manifestation of immune reconstitution syndrome, because herpes zoster may had similar CD4 cell counts before starting anti-HIV treatment, but who
<< Home